NO903169D0 - 4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION. - Google Patents

4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION.

Info

Publication number
NO903169D0
NO903169D0 NO903169A NO903169A NO903169D0 NO 903169 D0 NO903169 D0 NO 903169D0 NO 903169 A NO903169 A NO 903169A NO 903169 A NO903169 A NO 903169A NO 903169 D0 NO903169 D0 NO 903169D0
Authority
NO
Norway
Prior art keywords
benzoxadiazines
preparation
Prior art date
Application number
NO903169A
Other languages
Norwegian (no)
Other versions
NO903169L (en
Inventor
Jean-Luc Malleron
Daniel Mansuy
Daniel Varech
Guyen Thie-Vuong N
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO903169D0 publication Critical patent/NO903169D0/en
Publication of NO903169L publication Critical patent/NO903169L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C07D253/10—Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90903169A 1989-07-17 1990-07-16 4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION. NO903169L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8909590A FR2649612A1 (en) 1989-07-17 1989-07-17 DRUGS BASED ON 1H-BENZOXADIAZINE DERIVATIVES-4.1.2 NOVEL DERIVATIVES AND METHODS FOR PREPARING THEM

Publications (2)

Publication Number Publication Date
NO903169D0 true NO903169D0 (en) 1990-07-16
NO903169L NO903169L (en) 1991-01-18

Family

ID=9383843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903169A NO903169L (en) 1989-07-17 1990-07-16 4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION.

Country Status (8)

Country Link
EP (1) EP0410834A1 (en)
JP (1) JPH0352876A (en)
CA (1) CA2021250A1 (en)
FI (1) FI903589A0 (en)
FR (1) FR2649612A1 (en)
IE (1) IE902587A1 (en)
NO (1) NO903169L (en)
PT (1) PT94729A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US6077869A (en) * 1998-10-29 2000-06-20 Ortho-Mcneil Pharmaceutical, Inc. Aryl phenylhydrazides as selective COX-2 inhibitors for treatment of inflammation
AU2006275514B2 (en) * 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
US8053440B2 (en) 2007-02-01 2011-11-08 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular diseases
EP2382194B1 (en) 2009-01-08 2014-03-12 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
JP5795304B2 (en) 2009-03-18 2015-10-14 レスバーロジックス コーポレイション New anti-inflammatory agent
KR101892987B1 (en) 2009-04-22 2018-08-30 리스버로직스 코퍼레이션 Novel anti-inflammatory agents
DK2773354T3 (en) 2011-11-01 2019-08-05 Resverlogix Corp ORAL FORMS WITH IMMEDIATE RELEASE FOR SUBSTITUTED QUINAZOLINONS
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
AU2013365926B9 (en) 2012-12-21 2019-01-17 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
KR102662814B1 (en) 2015-03-13 2024-05-03 리스버로직스 코퍼레이션 Compositions and treatment methods for treating complement-related diseases
CN114349656B (en) * 2022-01-18 2024-03-29 赣南师范大学 Preparation method of hydrazide compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH487171A (en) * 1963-10-22 1970-03-15 Siegfried Ag Process for the preparation of therapeutically active 1,2-dihydro-1,2,4-benzotriazines

Also Published As

Publication number Publication date
NO903169L (en) 1991-01-18
EP0410834A1 (en) 1991-01-30
CA2021250A1 (en) 1991-01-18
PT94729A (en) 1991-03-20
JPH0352876A (en) 1991-03-07
FI903589A0 (en) 1990-07-16
FR2649612A1 (en) 1991-01-18
IE902587A1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
NO902661D0 (en) RIBOZYMS, THEIR PREPARATION AND USE.
DK374389A (en) ARYLBENZENOXAZOLIDINONES, THEIR PREPARATION AND USE
NO900469D0 (en) PIPERIDE CONNECTIONS, THEIR PREPARATION AND USE.
NO912960D0 (en) POLYLACTIDES, THEIR PREPARATION AND USE.
NO875358L (en) 6-BENZOCSAZINYL AND 6-BENZOTIAZINYL-2,3,4,5-TETRAHYDROPYRIDAZINE-3-ONES AND PROCEDURES FOR THEIR PREPARATION.
DK462187D0 (en) PYRIDINYL-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND USE.
NO870512L (en) 1,4-BENZOCSAZINE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO902279L (en) BENZOCYCYCLOAL CANDY DERIVATIVES AND THEIR PREPARATION.
NO903169D0 (en) 4,1,2-1H-BENZOXADIAZINES AND THEIR PREPARATION.
DK388989A (en) ACYLCYANOGUANIDINES, THEIR PREPARATION AND USE
NO903096D0 (en) THERMOTROP SEMIALIFATIC COPOLYESTERAMIDS AND THEIR PREPARATION.
NO903978L (en) PYRIDINYL-QUINOLONE COMPOUNDS, THEIR PREPARATION AND USE.
DK435289D0 (en) PIPERAZINDIONS, THEIR PREPARATION AND USE
NO900943D0 (en) COPOLYMERS, THE PROCEDURE FOR THEIR PREPARATION AND USE.
NO912271D0 (en) SOMATOSTATIN PREPARATIONS, THEIR PREPARATION AND USE.
DK225089D0 (en) 2-ADAMANTYL-4-ISOTHIAZOLIN-3-ONES, THEIR PREPARATION AND USE
NO164652C (en) POLYFLUORAL CHYLTYMETHYL COMPOUNDS, THEIR PREPARATION AND USE.
NO924343D0 (en) SUBSTITUTED 1.5 PENTANDIOLS AND THEIR PREPARATION
NO892570L (en) POLYSILAZANES, THEIR PREPARATION AND USE.
NO874926D0 (en) COPOLYMERS, THEIR PREPARATION AND USE.
DK388986A (en) 7-OXO-4-THIA-1-AZABICYCLO (3.2.0) HEPT-2-EN-DERIVATIVES, THEIR PREPARATION AND USE
DK592389A (en) PENEMDERIVATIVES, THEIR PREPARATION AND USE
NO901199D0 (en) AZOL-1 ALKANAMIDES AND THEIR PREPARATION.
NO872885L (en) 1,3,5-TRITIAN DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION.
NO885020D0 (en) ISOQINOLINE DERIVATIVES, THEIR PREPARATION AND USE.